Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 231 - 240 of 688 shown below

  • Ohi, Y

    N A Khan, A Castillo, C Koriyama, Y Kijima, Y Umekita, Y Ohi, M Higashi, Y Sagara, H Yoshinaka, T Tsuji, S Natsugoe, T Douchi, Y Eizuru and S Akiba

    Human papillomavirus detected in female breast carcinomas in Japan

    advance online publication, 2008-07-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604502

  • Ohira, M

    K Katsuragi, M Yashiro, T Sawada, H Osaka, M Ohira and K Hirakawa

    Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection

    advance online publication, 2007-07-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603909

  • S Honda, Y Arai, M Haruta, F Sasaki, M Ohira, H Yamaoka, H Horie, A Nakagawara, E Hiyama, S Todo and Y Kaneko

    Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

    advance online publication, 2008-10-28 00:00:00.000;

    doi:10.1038/sj.bjc.6604754

  • M Yashiro, O Shinto, K Nakamura, M Tendo, T Matsuoka, T Matsuzaki, R Kaizaki, M Ohira, A Miwa and K Hirakawa

    Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

    doi:10.1038/sj.bjc.6605296

  • H Teraoka, T Sawada, T Nishihara, M Yashiro, M Ohira, T Ishikawa, H Nishino and K Hirakawa

    Enhanced VEGF production and decreased immunogenicity induced by TGF- beta 1 promote liver metastasis of pancreatic cancer

    doi:10.1054/bjoc.2001.1941

  • Ohira, T

    Y Gong, T Hirano, Y Kato, K Yoshida, Y Shou, T Ohira, N Ikeda, Y Ebihara and H Kato

    Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis

    doi:10.1038/sj.bjc.6600327

  • J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y Suga, T Ohira, K Mukai and H Kato

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

    advance online publication, 2008-01-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604197

  • J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y Suga, T Ohira, K Mukai and H Kato

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy

    doi:10.1038/sj.bjc.6604414

  • Y Shou, T Hirano, Y Gong, Y Kato, K Yoshida, T Ohira, N Ikeda, C Konaka, Y Ebihara, F Zhao and H Kato

    Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

    doi:10.1054/bjoc.2001.2137

  • Ohizumi, I

    S Tsunoda, I Ohizumi, J Matsui, K Koizumi, Y Wakai, H Makimoto, Y Tsutsumi, N Utoguchi, K Taniguchi, H Saito, N Harada, Y Ohsugi and T Mayumi

    Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

    doi:10.1038/sj.bjc.6690823

  • Ohkawa, K

    T Asakura, T Sawai, Y Hashidume, Y Ohkawa, S Yokoyama and K Ohkawa

    Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate

    doi:10.1038/sj.bjc.6690414

  • S Isonishi, K Ohkawa, T Tanaka and S B Howell

    Depletion of protein kinase C (PKC) by 12- O -tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells

    doi:10.1054/bjoc.1999.0873

  • Ohkawa, Y

    T Asakura, T Sawai, Y Hashidume, Y Ohkawa, S Yokoyama and K Ohkawa

    Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate

    doi:10.1038/sj.bjc.6690414

  • Ohkubo, T

    A Fujita, T Ohkubo, H Hoshino, H Takabatake, S Tagaki, K Sekine and S Abe

    Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

    doi:10.1038/sj.bjc.6601230

  • Ohkuri, T

    T Ohkuri, D Wakita, K Chamoto, Y Togashi, H Kitamura and T Nishimura

    Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells

    advance online publication, 2009-03-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604966

  • Ohkusa, T

    H J N Andreyev, A R Norman, D Cunningham, J Oates, B R Dix, B J Iacopetta, J Young, T Walsh, R Ward, N Hawkins, M Beranek, P Jandik, R Benamouzig, E Jullian, P Laurent-Puig, S Olschwang, O Muller, I Hoffmann, H M Rabes, C Zietz, C Troungos, C Valavanis, S T Yuen, J W C Ho, C T Croke, D P O'Donoghue, W Giaretti, A Rapallo, A Russo, V Bazan, M Tanaka, K Omura, T Azuma, T Ohkusa, T Fujimori, Y Ono, M Pauly, C Faber, R Glaesener, A F P M de Goeij, J W Arends, S N Andersen, T Lövig, J Breivik, G Gaudernack, O P F Clausen, P De Angelis, G I Meling, T O Rognum, R Smith, H-S Goh, A Font, R Rosell, X F Sun, H Zhang, J Benhattar, L Losi, J Q Lee, S T Wang, P A Clarke, S Bell, P Quirke, V J Bubb, J Piris, N R Cruickshank, D Morton, J C Fox, F Al-Mulla, N Lees, C N Hall, D Snary, K Wilkinson, D Dillon, J Costa, V E Pricolo, S D Finkelstein, J S Thebo, A J Senagore, S A Halter, S Wadler, S Malik, K Krtolica and N Urosevic

    Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

    doi:10.1054/bjoc.2001.1964

  • Ohlsson, L

    L Ohlsson, M-L Hammarström, A Israelsson, L Näslund, Å Öberg, G Lindmark and S Hammarström

    Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR

    advance online publication, 2006-06-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603206

  • M J Litton, M Dohlsten, A Rosendahl, L Ohlsson, M Søgaard, J Andersson and U Andersson

    The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens

    doi:10.1038/sj.bjc.6690701

  • G Forsberg, L Ohlsson, T Brodin, P Björk, P A Lando, D Shaw, P L Stern and M Dohlsten

    Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen

    doi:10.1054/bjoc.2001.1891